High impact
Extended-Release Buprenorphine Injectables (CPB 0910, reviewed 2025-12-30)
Aetna·Effective Dec 30, 2025
HCPCS G0516 is officially defined as "Insertion of non-biodegradable drug delivery implants, 4 or more (services for subdermal rod implant)." HCPCS G0516 is referenced in 1 tracked payer policy change from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS G0516 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.